Di Nuzzo Private Wealth, Inc. Bridge Bio Pharma, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 23 shares of BBIO stock, worth $602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 22
4.55%
Holding current value
$602
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
290Shares Held
170MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$662 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$658 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$372 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$326 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$159 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.89B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...